Our study showed that five parameters were lower in the HER2-positive group than that in the HER2-negative group, which might be explained by the higher cellular density and the higher rate of cell proliferation and cellularity in HER2-positive breast cancer (32). This evidence concerns the gene ERBB2 and breast carcinoma.